Publications
- Addition of rituximab significantly improves outcomes in patients with diffuse large B-cell lymphoma a single-center, retrospective study2007 | Faculty of Medicine in Hradec Králové
- The non-Hodkgin's lymphoma subtypes distribution and survival in Czech Republic +12007 | Publication without faculty affiliation
- Current approaches and new trends in the treatment of patients with follicular lymphomas2004 | Faculty of Medicine in Hradec Králové
- Addition of rituximab significantly improves outcome in patients with diffuse large B-cell lymphoma +1Publication without faculty affiliation
- Rituximab Combination with Anthracyclin Based Chemotherapy Significantly Improved the Outcome of Young Patients with Diffuse Large B-Cell Lymphoma in Low as Well in High Risk SubgroupsPublication without faculty affiliation
- Rituximab improves outcome in patients with diffuse large B-cell lymphoma. A single centre retrospective studyPublication without faculty affiliation
- Rituximab improves outcome in patients with difuse large B-cell lymphoma (DLBCL) - single centre retrospective studyPublication without faculty affiliation
- Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic2023 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Brentuximab vedotin consolidation therapy after autologous stem cell transplantation in relapsed/refractory classic Hodgkin lymphoma patients in the Czech Republic2023 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era2023 | Faculty of Medicine in Hradec Králové
Loading network view...